Research News and Research

RSS

ZIOPHARM second-quarter net loss from operations increases to $5.1 million

ZIOPHARM Oncology, Inc., a biopharmaceutical cancer company addressing unmet medical needs, today reported its financial results for the three months ended June 30, 2010 and provided an update on the Company's continued progress with its clinical programs.

30 Jul 2010

Paperwork for reimbursement prevents PCTs access to high-cost cancer drugs

The amount of paperwork that primary care trusts (PCTs) have to fill out in order to be reimbursed for cancer drugs is so great that they may be missing out on millions of pounds, a report suggests.

30 Jul 2010

Opportunity in European embolization coil market leads to major acquisitions in 2010: MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets.

30 Jul 2010

Higher case volume associated with better outcomes of cardiac surgery: Study

A new analysis led by researchers at UCSF shows that avoiding lowest-volume hospitals and maximizing adherence to quality care processes are both effective approaches to reducing costs associated with coronary bypass surgery.

30 Jul 2010

$Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released$

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Millennium: The Takeda Oncology Company today reported new correlative science data from the pivotal PINNACLE trial of VELCADE (bortezomib) in patients with relapsed/refractory mantle cell lymphoma. The data, derived from an analysis of archived tumor samples, tested pre-specified biomarkers for their association with time to progression and response to treatment with VELCADE in patients with relapsed MCL.

30 Jul 2010

Volcano second-quarter revenues increase 36% to record $73.5 million

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues in the second quarter of 2010 increased 36 percent versus revenues in the second quarter of 2009.

30 Jul 2010

VAPAHCS acquires 15 Zargis Cardioscan systems

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that the VA Palo Alto Health Care System, a northern California based hospital group that is part of The Department of Veterans Affairs nationwide network of hospitals, recently purchased 15 Zargis Cardioscan systems.

30 Jul 2010

Down the silk road of the future

The Science paper notes that the development of silk hydrogels, films, fibers and sponges is making possible advances in photonics and optics, nanotechnology, electronics, adhesives and microfluidics, as well as engineering of bone and ligaments. Because silk fiber formation does not rely on complex or toxic chemistries, such materials are biologically and environmentally friendly, even able to integrate with living systems.

30 Jul 2010

Scientist examines relationship between stress of human isolation, immune system

A remote Canadian island is being used to simulate isolated space flight conditions for a NASA-funded medical research study that could produce important information to assist astronauts in potential long duration flights to Mars or an asteroid.

30 Jul 2010

First Edition: July 30, 2010

In today's headlines, a report about the administration's new high-risk pool regulations and how they address abortion coverage, as well as other details related to the new health law and the insurance marketplace.

30 Jul 2010

Partners in ENIAC project announce details of multinational/multidisciplinary program

The partners in a new publicly-funded European research project today announced details of the multinational/multidisciplinary program: 'CSI: Central Nervous System Imaging.' This three-year ENIAC project aims to achieve substantial advances in state-of-the-art medical 3D-imaging platforms by focusing on the diagnosis and therapy of serious diseases of the central nervous system and brain.

30 Jul 2010

Intrinsic brain connectivity in fibromyalgia associated with chronic pain intensity

A recent study from researchers at Massachusetts General Hospital and University of Michigan provides the first direct evidence of linkage between elevated intrinsic (resting-state) brain connectivity and spontaneous pain intensity in patients with fibromyalgia (FM). This research shows an interaction of multiple brain networks, offering greater understanding of how pain arises. Details of the study appear online and in the August issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

30 Jul 2010

Cancer Research UK launches new £18 million Biotherapeutics Development Unit

Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today (Friday) with the manufacture of its first product - an antibody for treating a range of cancers.

30 Jul 2010

Exoskeletons, powered prostheses and optical sensory devices market to exceed $877 million in 2020: Study

Lockheed Martin announced recently that it has received a $1.1-million contract from the US Army for human trials and evaluation of its advanced ruggedized Human Universal Load Carrier (HULC) exoskeleton, "designed to augment soldiers' strength and endurance, as well as reduce load carriage injuries."

30 Jul 2010

Pancreas surgery specialist performs 1,000th Whipple procedure

Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.

30 Jul 2010

HSFC supports SWG's report on reducing sodium levels

The Heart and Stroke Foundation of Canada strongly supports the report released today by the Sodium Working Group.

30 Jul 2010

Gen-Probe second-quarter 2010 product sales up 14%

Gen-Probe Incorporated today reported financial results for the second quarter of 2010, highlighted by 14% growth in product sales, 15% growth in total revenues, and 16% growth in non-GAAP earnings per share.

30 Jul 2010

Governor Rendell announces $2.5M investment to help boost higher education, health care industries

Colleges, universities, academic medical institutions and research institutions across Pennsylvania will be better able to recruit top faculty researchers and get products to the marketplace faster with a new $2.5 million investment announced today by Governor Edward G. Rendell.

30 Jul 2010

Researchers test AACTP, LEAP programmes that help problem drinkers curb alcohol abuse

A study by a team of researchers at Bangor University has designed and tested two programmes that help problem drinkers curb their alcohol abuse. The study shows positive results after drinkers have followed either the Alcohol Attention-Control Training Programme or the Life Enhancement and Advancement Programme.

30 Jul 2010

Resveratrol suppresses inflammation and free radicals: Study

Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.

30 Jul 2010

Research News and Research

ZIOPHARM second-quarter net loss from operations increases to $5.1 million

Paperwork for reimbursement prevents PCTs access to high-cost cancer drugs

Opportunity in European embolization coil market leads to major acquisitions in 2010: MRG

Higher case volume associated with better outcomes of cardiac surgery: Study

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Volcano second-quarter revenues increase 36% to record $73.5 million

VAPAHCS acquires 15 Zargis Cardioscan systems

Down the silk road of the future

Scientist examines relationship between stress of human isolation, immune system

First Edition: July 30, 2010

Partners in ENIAC project announce details of multinational/multidisciplinary program

Intrinsic brain connectivity in fibromyalgia associated with chronic pain intensity

Cancer Research UK launches new £18 million Biotherapeutics Development Unit

Exoskeletons, powered prostheses and optical sensory devices market to exceed $877 million in 2020: Study

Pancreas surgery specialist performs 1,000th Whipple procedure

HSFC supports SWG's report on reducing sodium levels

Gen-Probe second-quarter 2010 product sales up 14%

Governor Rendell announces $2.5M investment to help boost higher education, health care industries

Researchers test AACTP, LEAP programmes that help problem drinkers curb alcohol abuse

Resveratrol suppresses inflammation and free radicals: Study

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence